Mereo BioPharma Group plc Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 15.31 M | $62.91 M | 0.00% | 9.94% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 12.35 M | $50.86 M | 56.66% | 8.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 9.72 M | $39.93 M | -17.61% | 6.31% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 9.53 M | $39.19 M | 2.70% | 6.19% |
MANGROVE PARTNERS | 11/14/2024 | 8.73 M | $35.88 M | -0.26% | 5.67% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 6.71 M | $27.58 M | 0.00% | 4.36% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 5.39 M | $22.17 M | 68.49% | 3.50% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 5.10 M | $20.95 M | 15.82% | 3.31% |
683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.85 M | $19.93 M | -3.00% | 3.15% |
ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 4.70 M | $19.31 M | 0.00% | 3.05% |
CLEARLINE CAPITAL LP | 11/14/2024 | 3.24 M | $13.33 B | -2.48% | 2.11% |
TEJARA CAPITAL LTD | 11/13/2024 | 2.83 M | $11.63 M | 8.20% | 1.84% |
MORGAN STANLEY | 11/14/2024 | 2.35 M | $9.65 M | 1,030.20% | 1.52% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.01 M | $8.25 M | -19.91% | 1.30% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.31 M | $5.37 M | -25.92% | 0.85% |
ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 1.26 M | $5.18 M | 86.22% | 0.82% |
MARSHALL WACE, LLP | 11/14/2024 | 1.03 M | $4.23 M | -10.10% | 0.67% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 1.00 M | $4.11 M | -43.66% | 0.65% |
BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 847,809 | $3.48 M | -5.57% | 0.55% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 846,953 | $3.48 M | -32.08% | 0.55% |
NEOS INVESTMENT MANAGEMENT LLC | 11/13/2024 | 835,194 | $3.43 M | -12.95% | 0.54% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 815,722 | $3.35 M | -34.91% | 0.53% |
EVERSEPT PARTNERS, LP | 11/14/2024 | 777,890 | $3.20 M | 56.78% | 0.51% |
ARTIA GLOBAL PARTNERS LP | 11/14/2024 | 421,359 | $1.73 M | 0.00% | 0.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 386,430 | $1.59 M | -54.01% | 0.25% |
MONACO ASSET MANAGEMENT SAM | 11/07/2024 | 384,535 | $1.58 M | 10.46% | 0.25% |
KNOTT DAVID M JR | 11/13/2024 | 331,000 | $1.36 M | 40.25% | 0.21% |
KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2024 | 260,470 | $1.07 M | 0.00% | 0.17% |
J. GOLDMAN & CO LP | 11/14/2024 | 254,890 | $1.05 M | 11.85% | 0.17% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 217,557 | $894,159 | 158.94% | 0.14% |
JANE STREET GROUP, LLC | 11/15/2024 | 214,635 | $882,150 | 153.73% | 0.14% |
JANE STREET GROUP, LLC | 11/15/2024 | 208,400 | $856,524 | 100.00% | 0.14% |
HEALTHINVEST PARTNERS AB | 11/12/2024 | 200,000 | $822,000 | 100.00% | 0.13% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 198,300 | $815,013 | 36.01% | 0.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 192,000 | $789,120 | 106.45% | 0.12% |
HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 175,000 | $719,250 | 100.00% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 157,100 | $645,681 | 46.14% | 0.10% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 134,313 | $552,026 | -33.43% | 0.09% |
CITADEL ADVISORS LLC | 11/14/2024 | 130,258 | $535,361 | -68.15% | 0.08% |
CITADEL ADVISORS LLC | 11/14/2024 | 113,600 | $466,896 | 13.26% | 0.07% |
VERITION FUND MANAGEMENT LLC | 11/14/2024 | 110,004 | $452,116 | -51.43% | 0.07% |
FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 102,582 | $421,612 | 108.06% | 0.07% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 92,156 | $378,761 | 0.00% | 0.06% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 67,069 | $276,000 | 100.00% | 0.04% |
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 54,000 | $221,940 | 0.00% | 0.04% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 49,687 | $204,214 | 49.27% | 0.03% |
STATE STREET CORP | 11/14/2024 | 47,561 | $195,476 | 100.00% | 0.03% |
CLEAR HARBOR ASSET MANAGEMENT, LLC | 10/24/2024 | 43,500 | $178,785 | 0.00% | 0.03% |
SIMPLEX TRADING, LLC | 11/08/2024 | 33,855 | $139,000 | -18.21% | 0.02% |
FOREFRONT ANALYTICS, LLC | 11/14/2024 | 33,800 | $138,915 | -6.71% | 0.02% |
Mereo BioPharma Group plcinstitutional Ownership - FAQ's
During the previous two years, 92 institutional investors and hedge funds held shares of Mereo BioPharma Group plc. The most heavily invested institutionals were:
Rubric Capital Management LP: 15.31 M
JANUS HENDERSON GROUP PLC: 12.35 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 9.72 M
Rock Springs Capital Management LP: 9.53 M
MANGROVE PARTNERS: 8.73 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 6.71 M
68.65% of Mereo BioPharma Group plc stock is owned by institutional investors.
Institutional investors have bought a total of 107.53 M shares in the last 24 months. This purchase volume represents approximately $323.68 M in transactions.